A
$ Value
$0
Shares
52,762
Price
$0
Filed
Apr 14
Insider
Name
Anagnost Andrew
Title
President and CEO
CIK
0001661768
Roles
Director
Officer
Transaction Details
Transaction Date
2026-04-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
200,503
Footnotes
These Restricted Stock Units vest as to approximately 1/2 of the total shares on an approximate annual basis over a 2-year period from the date of grant on April 10, 2026. | Includes shares acquired in March 2026 pursuant to the Issuer's Employee Stock Purchase Plan. | The total securities beneficially owned includes 85,344 hares of unvested Restricted Stock Units.
Filing Info
Anagnost Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | ADSK | A | $0 |
| 2026-03-24 | ADSK | F | $5.2M |
| 2026-03-24 | ADSK | A | $0 |
| 2026-03-24 | ADSK | F | $5.3M |
| 2025-12-02 | ADSK | G | $0 |
| 2025-06-04 | HUBS | A | $0 |
Other Insiders at ADSK (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Blum Steven M
EVP, Chief Operating Officer
|
— | — | 2026-04-10 |
|
Anagnost Andrew
President and CEO
|
— | — | 2026-03-24 |
|
Moorjani Janesh
EVP, Chief Financial Officer
|
— | — | 2026-04-10 |
|
Keene Ruth Ann
EVP, Corp Affairs, CLO
|
— | — | 2026-04-10 |
|
Pearce Rebecca
EVP, Chief People Officer
|
— | — | 2026-04-10 |